Public Sector Pension Investment Board grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 8.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 172,373 shares of the medical equipment provider’s stock after purchasing an additional 13,150 shares during the period. Public Sector Pension Investment Board’s holdings in Intuitive Surgical were worth $84,682,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also modified their holdings of ISRG. Ridgewood Investments LLC acquired a new position in shares of Intuitive Surgical in the second quarter worth about $26,000. Godsey & Gibb Inc. lifted its position in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares in the last quarter. LGT Financial Advisors LLC boosted its stake in Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 54 shares during the period. MidAtlantic Capital Management Inc. purchased a new position in Intuitive Surgical during the 3rd quarter worth approximately $33,000. Finally, LRI Investments LLC acquired a new stake in Intuitive Surgical during the 1st quarter valued at $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.
Intuitive Surgical Stock Performance
ISRG opened at $538.55 on Thursday. The company has a market cap of $191.82 billion, a PE ratio of 86.58, a price-to-earnings-growth ratio of 5.28 and a beta of 1.39. The stock has a 50-day moving average of $507.94 and a 200-day moving average of $466.79. Intuitive Surgical, Inc. has a 52-week low of $304.50 and a 52-week high of $552.00.
Analyst Upgrades and Downgrades
ISRG has been the subject of several recent analyst reports. Citigroup raised their target price on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. BTIG Research raised their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday. Robert W. Baird lifted their target price on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. Piper Sandler reissued an “overweight” rating and issued a $538.00 price target (up from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Wells Fargo & Company boosted their price objective on shares of Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a research report on Friday, October 18th. One analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $526.06.
Read Our Latest Report on ISRG
Insider Buying and Selling
In other news, Director Amy L. Ladd sold 450 shares of Intuitive Surgical stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $490.28, for a total value of $220,626.00. Following the transaction, the director now directly owns 821 shares in the company, valued at approximately $402,519.88. The trade was a 35.41 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Jamie Samath sold 22,903 shares of the business’s stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $525.00, for a total value of $12,024,075.00. Following the transaction, the insider now directly owns 8,757 shares of the company’s stock, valued at $4,597,425. This represents a 72.34 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 50,459 shares of company stock valued at $26,080,251. Company insiders own 0.80% of the company’s stock.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading
- Five stocks we like better than Intuitive Surgical
- Breakout Stocks: What They Are and How to Identify Them
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What is a Bond Market Holiday? How to Invest and Trade
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.